JAPANESE FOUNDATION FOR CANCER RESEARCH

japanese-foundation-for-cancer-research-logo

The Japanese Cancer Research Foundation supports the establishment of a cancer institute and its affiliated hospital. It has been leading the research and treatment of cancer thru activities integrating basic and clinical research. It shows their accomplishments in cancer research and treatment over a long history. It is one of the the world-s institutes in bioscience. They are making accomplishments in the treatment of cancer its related diseases with efficient medical staff and leading-edge medical equipment.

#Website #More

JAPANESE FOUNDATION FOR CANCER RESEARCH

Industry:
Health Care Health Diagnostics Wellness

Founded:
1908-04-02

Address:
Koto, Tokyo, Japan

Country:
Japan

Website Url:
http://www.jfcr.or.jp

Total Employee:
1001+

Status:
Active

Contact:
+81 03 3520 0111

Technology used in webpage:
SPF LetsEncrypt Content Delivery Network Google Universal Analytics Font Awesome Microsoft Exchange Online Office 365 Mail JsDelivr ASP.NET IIS


Official Site Inspections

http://www.jfcr.or.jp Semrush global rank: 250.83 K Semrush visits lastest month: 276.36 K

  • Host name: extsvr1.jfcr.or.jp
  • IP address: 202.242.5.13
  • Location: Japan
  • Latitude: 35.69
  • Longitude: 139.69
  • Timezone: Asia/Tokyo

Loading ...

More informations about "Japanese Foundation for Cancer Research"

Japanese Foundation For Cancer Research - jfcr.or.jp

Japanese Foundation For Cancer Research. 3-8-31, Ariake, Koto, Tokyo 135-8550, Japan Tel:+81-3-3520-0111 Fax:+81-3-3520-0141See details»

About Us|JFCR - jfcr.or.jp

In January 2001, JFCR had the honor of receiving His Imperial Highness Prince Hitachi, who had been engaged in research of animal cancer for long time as a visiting professor, as Honorary President. ... Organization. Learn more about …See details»

Japanese Foundation for Cancer Research - Wikipedia

The Japanese Foundation for Cancer Research (公益財団法人がん研究会) (JFCR) is a non-profit cancer research organization based in Ariake, Tokyo. The JFCR was founded in 1908 as the first Japanese organization specializing in cancer by Katsusaburō Yamagiwa and his supporters. The Cancer Institute and its attached hospital of JFCR were set up in 1934. The JFCR became a full m…See details»

The 28th JFCR-ISCC | December 11-12, 2024 - iscc.umin.jp

The 28th JFCR-ISCC December 11-12, 2024 Miraikan - The National Museum of Emerging Science and Innovation 7F 2-3-6, Aomi, Koto-ku, Tokyo, Japan. December 11. 12:00-12:30. …See details»

Japanese Foundation for Cancer Research (JFCR) - UICC

Jul 27, 2024 Japanese Foundation for Cancer Research is a non-governmental, non-profit organization founded in 1908. After a quarter century of tough fund-rasing struggles, largely …See details»

Parexel and Japanese Foundation for Cancer Research Announce …

Jan 10, 2024 “Parexel and JFCR enter into this strategic alliance driven by a shared sense of urgency to enable sponsors to conduct trials in Japan and ensure these patients have access …See details»

Cancer Institute Hospital of JFCR - jfcr.or.jp

JFCR was founded in 1908 as the first organization in Japan specializing in the treatment and research of cancer. ... +81-3-3570-0383 (Mon-Fri 9am-5pm) [email protected]. After hours, …See details»

Japanese Foundation for Cancer Research-International …

Mar 27, 2019 25th JFCR-ISCC information will be held on December 8-9, 2021, in Tokyo. Hybrid Meeting (On Site and Zoom)Miraikan : 2019.03.27: 24th JFCR-ISCC information will be held …See details»

Parexel and Japanese Foundation for Cancer Research

Jan 10, 2024 About Japanese Foundation for Cancer Research (JFCR) Since its establishment 115 years ago, the Japanese Foundation for Cancer Research (JFCR) has been the largest …See details»

Managing a gastrointestinal oncology practice in Japan during

Coronavirus disease 2019 (COVID-19) was declared to be a global pandemic by the World Health Organization on March 11, 2020. On April 7, 2020, a state of emergency was declared in …See details»

Ramucirumab for the treatment of metastatic gastric or ... - PubMed

1 Saitama Cancer Center, Saitama, Japan. [email protected]. 2 Department of Gastroenterological Chemotherapy, Cancer Institute Hospital of Japanese Foundation for …See details»

Outline|About The Cancer Institute of JFCR|Cancer Institute

Japanese Foundation for Cancer Research (JFCR) is a non-governmental non-profit organization established in 1908. The first chairman was Dr. Katsusaburo Yamagiwa, who is world-famous …See details»

Comprehensive registry of esophageal cancer in Japan, 2014

Affiliations 1 Department of Gastroenterological Surgery, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan. …See details»

Japanese Foundation For Cancer Research - jfcr.or.jp

Adopted by JFCR as its logo. The Japanese Foundation for Cancer Research (JFCR) was founded in 1908 as the first organization in Japan to specialize in cancer. For over a century …See details»

Japanese Foundation for Cancer Research - ZoomInfo

View Japanese Foundation for Cancer Research (jfcr.or.jp) location in Tokyo, Japan , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»

A phase II study of modified FOLFIRINOX for chemotherapy

Affiliations 1 Department of Gastroenterology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan. …See details»

兵庫 斎藤知事が所信表明 “ハラスメントのない組織づくりを” | NHK

1 day ago 斎藤知事はことし9月に県議会が全会一致で不信任を議決したのを受けて失職し、11月の選挙で再び当選しました。 3日は、再選後初めての定例県 ...See details»

お知らせ - jfcr.or.jp

13 hours ago ①12月11日(水)午前6:10~午前6:25 泌尿器のがん 体の負担が少ない治療 「前立腺がん いつどんな治療を始めるか?」See details»

お知らせ - jfcr.or.jp

2 days ago 公益財団法人がん研究会(所在地:東京都江東区、理事長:浅野 敏雄、以下 がん研究会)と、toppan ホールディングス株式会社(本社:東京都文京区、代表取締役社長ceo: …See details»

NEXT-Ganken Program | JFCR - jfcr.or.jp

The program establishes a new research promotion system enabling the Cancer Institute Hospital of JFCR to collaborate with research systems a closer level than ever, elucidating pathology in …See details»